Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Sky One’s Q2 Beats Estimates

publication date: Aug 12, 2008

China Sky One Medical, Inc. released a very positive Q2 earnings report that also beat analysts’ expectations. Revenues increased 62% to $23.7 million, and net income jumped 92% to $8.1 million or 50 cents per diluted share. Those results were higher than street estimates of $19.5 million and 37 cents per share. In addition to the numbers, China Sky One took pains to point to a number of company accomplishments during the quarter. More details...

Stock Symbols: (AMEX: CSY)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital